Stephane Bancel CEO of Moderna
In Good Company with Nicolai Tangen
Vaccine Development in a Crisis
This chapter covers Moderna's urgent response to the COVID-19 pandemic and the ethical considerations of developing a vaccine in a global health crisis. It highlights the innovative use of mRNA technology and the commitment to public welfare, alongside the challenges faced by the scientific community during this unprecedented time.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
